20 May 2003 : Original article
Comparative effectiveness of L-ornitine L-aspartate vs.essential phospholipids in complex treatment of the patients with alcoholic abstinence and liver disorder
I. Vlokh, N. Petryna, J. Denysyuk, V. VdovitchenkoMed Sci Monit 2003; 9(2): 17-0 :: ID: 15276
Abstract
Alcoholic abstinence treatment is complicated for the liver dysfunction in these patients.There are many drugs used for a cur Essential phospholipids are the classic hepatoprotector in rehabilitation of patients with alcoholic hepatic encephalopathy, but effectiveness of L-ornitine-L-aspartate in a long treatment is unclear.Aim of this work was to compare effectiveness of both drugs in complex therapy of hepatic encephalopathy in alcoholics. 2 groups of the patients (on 15 men in each,ranger of age 39 –60 years)were observed.All patients had clinical symptoms and biochemical tests peculiar for alcoholic hepatitis.The 1st group patients took psychotropics,metabolic drugs, anticovulsants and essential phospholipides (Essetiale,Aventis) 6 capsules a day for 5 –8 weeks.The 2 nd group patients took the same drugs and so long but L-ornitine-L-aspsrtate (Hepa-Merz, Merz &Co.GmbH)30 g in granules a day place of Essentiale. In the patients of the 2 nd group symptoms of alcohol abstinence encephalopathy decreased,intelectual and mnestic sphere improved,biochemical tests (ALT, AST, AP, bilirubine) had normalized in 3 weeks of the treatment.In the patients of the 1st group these symptomes and biochemical tests had not reduced in 4 weeks even. So,L-ornitine-L-aspartate in complex therapy of alcoholic encephalopathy has an undoubtedly preference.
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952